Neurocrine Biosciences (NBIX) Other Accumulated Expenses (2009 - 2026)
Neurocrine Biosciences (NBIX) posted Other Accumulated Expenses of $61.2 million for Q3 2026, up 14.0% from $53.7 million a year earlier but down 7.6% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences' Other Accumulated Expenses came in at $69.1 million, up 49.9% from FY2024.
- Annual Other Accumulated Expenses has increased for seven consecutive years, with a five-year compound annual growth rate of 31.2% (FY2020 to FY2025).
- In prior years, Neurocrine Biosciences' Other Accumulated Expenses was $46.1 million in FY2024 (+28.4%), $35.9 million in FY2023 (+73.4%), $20.7 million in FY2022 (+3.5%) and $20 million in FY2021 (+12.4%).
- Quarterly Other Accumulated Expenses has run from a low of $17.6 million in Q1 2022 to a high of $69.1 million in Q4 2025 over five years.
- On a year-over-year basis, Other Accumulated Expenses has increased in each of the last 16 quarters, with growth averaging 31.1% over the last eight quarters.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q1 2024, with growth of 99.5%; the weakest was Q3 2022, with a decline of 9.5%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $66.2 million (Q2 2026), $58.7 million (Q1 2026) and $69.1 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 61.20 Mn |
| Jun 30, 2026 | 66.20 Mn |
| Mar 31, 2026 | 58.70 Mn |
| Dec 31, 2025 | 69.10 Mn |
| Sep 30, 2025 | 53.70 Mn |
| Jun 30, 2025 | 56.80 Mn |
| Mar 31, 2025 | 47.70 Mn |
| Dec 31, 2024 | 46.10 Mn |
| Sep 30, 2024 | 37.00 Mn |
| Jun 30, 2024 | 40.00 Mn |
| Mar 31, 2024 | 36.70 Mn |
| Dec 31, 2023 | 35.90 Mn |
| Sep 30, 2023 | 18.70 Mn |
| Jun 30, 2023 | 21.20 Mn |
| Mar 31, 2023 | 18.40 Mn |
| Dec 31, 2022 | 20.70 Mn |
| Sep 30, 2022 | 18.10 Mn |
| Jun 30, 2022 | 20.00 Mn |
| Mar 31, 2022 | 17.60 Mn |
| Dec 31, 2021 | 20.00 Mn |
API Access
Neurocrine Biosciences Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();